Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ip, Carman K M ^a   Li, Shan Shan ^a   Tang, Matthew Y H ^a   Sy, Samuel K H ^a   Ren, Yong ^b   Shum, Ho Cheung ^a   Wong, Alice S T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF NOTTINGHAM NINGBO CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABCG2 PROTEIN, HUMAN; BREAST CANCER RESISTANCE PROTEIN; MICRORNA; MIRN199 MICRORNA, HUMAN; MULTIDRUG RESISTANCE PROTEIN 1; RNA; TUMOR PROTEIN;

ANIMAL; ASCITES; BAGG ALBINO MOUSE; CANCER STEM CELL; CARCINOMA; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HYDRODYNAMICS; LAB ON A CHIP; MOUSE; MULTICELLULAR SPHEROID; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SHEAR STRENGTH; SIGNAL TRANSDUCTION; TRANSPLANTATION; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; ASCITES; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 2; ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 1; CARCINOMA; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HETEROGRAFTS; HUMANS; HYDRODYNAMICS; LAB-ON-A-CHIP DEVICES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; RNA, NEOPLASM; SHEAR STRENGTH; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84973387007     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26788     Document Type: Article

References (44)

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5-29 (2015).
2. Bast, R. C. Jr., Hennessy, B. & Mills, G. B. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9, 415-428 (2009).
3. Bapat, S. A., Mali, A. M., Koppikar, C. B. & Kurrey, N. K. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65, 3025-3029 (2005).
4. Szotek, P. P. et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103, 11154-11159 (2006).
5. Zhang, S. et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68, 4311-4320 (2008).
6. Hu, L., McArthur, C. & Jaffe, R. B. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 102, 1276-1283 (2010).
7. Stewart, J. M. et al. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci USA 108, 6468-6473 (2010).
8. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
9. Burkhalter, R. J. et al. Peritoneal Mechanobiology and Metastatic Success in Epithelial Ovarian Cancer [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012; 72 (8 Suppl):Abstract nr 2472, doi: 1538-7445.AM2012-2472.
10. Avraham-Chakim, L. et al. Fluid-flow induced wall shear stress and epithelial ovarian cancer peritoneal spreading. PloS one 8, e60965 (2013).
11. Rizvi, I. et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci USA 110, E1974-1983 (2013).
12. Burdick, M. M., Chu, J. T., Godar, S. & Sackstein, R. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281, 13899-13905 (2006).
13. Lane, W. O. et al. Parallel-plate flow chamber and continuous flow circuit to evaluate endothelial progenitor cells under laminar flow shear stress. J Vis Exp. 59, 3349, doi: 10.3791/3349 (2012)
14. Ismadi, M. Z. et al. Flow characterization of a spinner flask for induced pluripotent stem cell culture application. PloS one 9, e106493 (2014).
15. Botta, G. P., Manley, P., Miller, S. & Lelkes, P. I. Real-time assessment of three-dimensional cell aggregation in rotating wall vessel bioreactors in vitro. Nat Protoc 1, 2116-212 (2006).
16. Yu, W. et al. A microfluidic-based multi-shear device for investigating the effects of low fluid-induced stresses on osteoblasts. PloS one 9, e89966 (2014).
17. Makhija, S., Taylor, D. D., Gibb, R. K. & Gercel-Taylor, C. Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids. Int J Oncol 14, 515-521 (1999).
18. Chau, W. K., Ip, C. K., Mak, A. S., Lai, H. C. & Wong, A. S. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling. Oncogene 32, 2767-2781 (2013).
19. Lee, J. M. et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest 93, 528-542 (2013).
20. Nagy, J. A., Herzberg, K. T., Dvorak, J. M. & Dvorak, H. F. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res 53, 2631-2643 (1993).
21. Peng, S., Maihle, N. J. & Huang, Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29, 2153-2159 (2010).
22. Kumar, S. M. et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31, 4898-4911 (2012).
23. Wang, Y. D. et al. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis 4, e760 (2013).
24. Zhang, J. et al. CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol 25, 456-464 (2012).
25. Schmandt, R. E. et al. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer 98, 758-764 (2003).
26. Raspollini, M. R. et al. c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study. Ann Oncol 15, 594-597 (2004).
27. Brustmann, H. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 98, 396-402 (2005).
28. Stordal, B. et al. Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein. PloS one 7, e40717 (2012).
29. Takahashi, R. U., Miyazaki, H. & Ochiya, T. The role of microRNAs in the regulation of cancer stem cells. Front Genet 4, 295 (2014).
30. Kinose, Y., Sawada, K., Nakamura, K. & Kimura, T. The role of microRNAs in ovarian cancer. Biomed Res Int 2014, 249393 (2014).
31. Wang, Y., Kim, S. & Kim, I. M. Regulation of metastasis by microRNAs in ovarian cancer. Front Oncol 4, 143 (2014).
32. Wang, K. C. et al. Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Proc Natl Acad Sci USA 107, 3234-3239 (2010).
33. Guan, Y. J., Yang, X., Wei, L. & Chen, Q. MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. Faseb J 25, 4457-4466 (2011).
34. Knuefermann, C. et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 22, 3205-3212 (2003).
35. Xia, P. & Xu, X. Y. PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res 5, 1602-1609 (2015).
36. Hamai, A. et al. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. Cancer Res 68, 9854-9864 (2008).
37. He, J. et al. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis. PloS one 8, e56647 (2013).
38. Kinose, Y. et al. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Oncotarget 6, 11342-11356 (2015).
39. Ashworth, A. et al. Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007. Gynecol Oncol 108, 652-657 (2008).
40. Fong, W. J., Tan, H. L., Choo, A. & Oh, S. K. Perfusion cultures of human embryonic stem cells. Bioprocess Biosyst Eng 27, 381-387 (2005).
41. Serra, M. et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 148, 208-215 (2010).
42. Titmarsh, D., Hidalgo, A., Turner, J., Wolvetang, E. & Cooper-White, J. Optimization of flowrate for expansion of human embryonic stem cells in perfusion microbioreactors. Biotechnol Bioeng 108, 2894-2904 (2011).
43. Gareau, T. et al. Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med 8, 268-278 (2014).
44. White, F. M. Viscous fluid flow. 2nd edn, Ch. 3, 104-211 (McGraw-Hill, 1974).